Table 3.
Effect of compound 11e on stages of the cell death process in HepG2 cells after 24 h treatment.
| Sample | Viablea (Left Bottom) |
Apoptosisa |
Necrosisa (Left Top) |
|
|---|---|---|---|---|
| Early (Right Bottom) |
Late (Right Top) |
|||
| HepG2 | 90.20 ± 1.07 | 9.58 ± 0.86 | 0.13 ± 0.01 | 0.10 ± 0.02 |
| Compound 11e /HepG2 | 50.65 ± 3.66 | 48.87 ± 3.69 | 0.27 ± 0.04 | 0.20 ± 0.03 |
aValues are reported as mean ± SD of three different experiments.